Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 343 participants.
Also called NCT01603082
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 343 participants
- Sponsor
- Registry
-
NCT01603082
-
- Other papers using this trial's data
- Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01603082. Randomized; no masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2014-06 (actual). Results posted on 2015-12-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct01603082- Content hash
e93d79e2ae182cbd972b27c892aa3d32f7f5d41634481ef64431f2fa7797c38e